two
topic
attract
recent
attent
field
autophagi
concern
sourc
membran
use
form
autophagosom
macroautophagi
role
noncanon
autophag
pathway
topic
may
converg
consid
intersect
autophagi
viral
infect
suggest
noncanon
autophagi
sensit
treatment
brefeldin
may
converg
infecti
cycl
certain
dna
rna
virus
util
membran
er
cisgolgi
altern
macroautophagyautophagi
report
increas
number
paper
sinc
first
describ
two
form
altern
autophagi
call
noncanon
autophagi
ii
autophagi
canon
autophagi
autophagosom
biogenesi
initi
erderiv
omegasom
via
phagophor
although
precis
mechan
defin
sourc
membran
donor
caus
ongo
debat
evid
point
golgi
apparatu
import
membran
sourc
autophagosom
format
one
distinct
featur
common
form
altern
autophagi
howev
inhibit
lacton
brefeldin
bfa
exert
disrupt
effect
cisgolgi
demarc
contribut
golgi
regard
autophagosom
biogenesi
prior
studi
canon
autophagi
inhibit
bfa
treatment
autophagi
pathway
first
document
mous
embryon
fibroblast
mef
lack
treatment
stressor
etoposid
lead
equal
number
autophagosom
per
cell
c
mef
furthermor
treatment
c
mef
suppress
autophagosom
format
howev
examin
autophagosom
cell
disclos
absenc
modif
furthermor
treatment
bfa
inhibit
autophagi
cell
c
cell
similar
result
obtain
mef
noncanon
autophagi
pathway
stimul
monounsatur
fatti
acid
oleat
origin
studi
compar
autophagi
induct
oleat
occur
respons
satur
fatti
acid
palmit
deplet
inhibit
autophag
induct
fatti
acid
howev
autophag
induct
oleat
requir
pathway
treatment
bfa
inhibit
oleateinduc
noncanon
autophagi
note
type
autophagi
previous
report
respons
mitochondri
damag
sensit
bfa
determin
describ
featur
common
form
altern
autophagi
inhibit
bfa
bfa
first
character
survey
antivir
activ
compound
extract
fungu
penicillium
brefeldianum
bfa
inhibit
differ
virus
includ
dna
viru
herp
simplex
viru
rna
viru
newcastl
diseas
viru
similar
mump
viru
bfa
subsequ
determin
inhibit
subset
gtpexchang
factor
catalyz
activ
small
gtpase
call
member
ra
superfamili
respons
recruit
coat
protein
vesicular
traffick
er
golgi
virologist
use
bfa
extens
decad
compound
inhibit
entri
virus
egress
other
entri
human
papillomaviru
polyomaviru
block
bfa
treatment
wherea
number
cytoplasm
replic
compart
coronaviru
reduc
bfa
likewis
egress
envelop
virus
herp
virus
paramyxovirus
newcastl
diseas
viru
block
bfa
mechan
origin
antivir
observ
reveal
biosynthesi
viral
glycoprotein
envelop
virus
requir
transfer
er
cisgolgi
process
glycan
step
inhibit
bfa
envelop
final
egress
matur
viral
particl
ebola
viru
envelop
rna
viru
also
appear
fall
latter
categori
virus
oblig
intracellular
parasit
appropri
hijack
cellular
organel
traffick
pathway
infecti
cycl
numer
role
canon
autophagi
viral
infecti
cycl
review
appar
discuss
multipl
dispar
virus
requir
compon
within
region
ercisgolgi
infecti
cycl
region
disrupt
treatment
bfa
region
overlap
site
autophagosom
format
altern
autophagi
region
may
correspond
one
membran
donor
canon
autophagi
exampl
vitro
evid
suggest
role
ergolgi
intermedi
compart
genet
data
support
involv
conserv
oligomer
golgi
complex
latter
pathway
rna
dna
virus
util
region
proceed
toward
product
infect
wherea
altern
autophagi
pathway
proce
toward
eventu
format
autolysosom
degrad
content
although
evid
site
geograph
intersect
altern
autophagi
viral
traffick
pathway
predict
common
process
yet
know
whether
viral
infect
may
interfer
altern
autophagi
within
infect
cell
whether
virus
reli
noncanon
autophag
pathway
replic
whether
altern
autophag
pathway
may
play
role
antimicrobi
respons
thu
research
studi
viral
traffick
pathway
follow
entri
egress
need
consid
potenti
consequ
intersect
canon
altern
autophagi
pathway
adp
ribosyl
factor
atg
autophagi
relat
beclin
bfa
brefeldin
er
endoplasm
reticulum
gtp
guanosin
triphosph
microtubuleassoci
protein
light
chain
mef
mous
embryo
fibroblast
potenti
conflict
interest
disclos
work
support
nih
grant
cg
djk
